Safety Study of 7 Botulinum Antitoxin Serotypes Derived From Horses
Clinical trial NCT00360737 · COMPLETED
Trial details
- NCT number
- NCT00360737
- Sponsor
- Emergent BioSolutions
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2006-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.